sdbn.org

Events, News, Syndication, Xconomy »

Announcing Xconomy’s Napa Summit: Keeping America Growing
Posted by sandiegobiotech April 26th, 2012 .
No Comments

As the Presidential campaign heats up, one of the most pressing issues on the minds of candidates and voters alike is the future of American growth and competitiveness. So it is our great pleasure to...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Illumina Opens Apple-Inspired App Store for DNA Software Developers
Posted by sandiegobiotech April 25th, 2012 .
No Comments

San Diego-based Illumina has talked openly about how it is inspired by the way Apple integrates hardware and software, and now it’s taking another cue from the consumer technology colossus. Illumina,...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

The JOBS Act—The “IPO On-Ramp” Makes IPOs Easier
Posted by sandiegobiotech April 24th, 2012 .
No Comments

Enacted with great fanfare in early April, the JOBS Act is intended to improve access to the public capital markets for startup companies. The cornerstone of the act is the creation of an “IPO on...

[[Click headline to continue reading.]] More...

Drug Development, News, Syndication, Xconomy »

AstraZeneca Reloads its Pipeline with Ardea Deal, Could be Still Hunting
Posted by sandiegobiotech April 23rd, 2012 .
No Comments

AstraZeneca (NYSE: AZN), the global pharmaceutical giant based in London, is replenishing its drug pipeline with its acquisition of San Diego’s Ardea Biosciences (NASDAQ: RDEA), which was disclosed...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Sapphire Energy CEO Jason Pyle’s Parting Thoughts on Big Biofuel
Posted by sandiegobiotech April 23rd, 2012 .
No Comments

After stepping down as the founding CEO of San Diego’s Sapphire Energy, Jason Pyle tells me he’s accomplished a number of key initiatives at the algae-based biofuels startup, and basically that it’s...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

What Are the Hottest Targets in Biotech Today?
Posted by sandiegobiotech April 23rd, 2012 .
No Comments

Hardly anybody wants new drugs that act like a sledgehammer, bashing diseased and healthy cells like old-school cancer chemotherapy. Many drugs today are supposed to be smart enough to work like...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

SD Life Sciences Roundup: Accelrys, Illumina, & RainTree Oncology
Posted by sandiegobiotech April 19th, 2012 .
No Comments

There was a mix of news out of San Diego’s life sciences community over the past week. Get your briefing here. —San Diego’s Sotera Wireless said the FDA has cleared its ViSi Mobile System, a wireless...

[[Click headline to continue reading.]] More...

Diagnostics, News, Syndication, Xconomy »

Illumina Stays Independent, Roche Walking Away
Posted by sandiegobiotech April 18th, 2012 .
No Comments

Illumina will remain an independent company, at least for now. The San Diego-based company (NASDAQ: ILMN), the market leading maker of DNA sequencing instruments, fended off a hostile takeover bid by...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Small is Beautiful in Q1 Venture Deals as VCs Write Lots of Checks
Posted by sandiegobiotech April 17th, 2012 .
No Comments

Venture investors wrote lots of checks during the first three months of 2012, but the amounts were small, according to the venture capital activity report being released today by CB Insights, the New...

[[Click headline to continue reading.]] More...

News, Syndication, Xconomy »

Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1
Posted by sandiegobiotech April 16th, 2012 .
No Comments

Sometimes the biggest success stories in business never make it to the magazine covers. There’s no single Eureka moment, no surprise turning point, no redemption, no swashbuckling CEO delivering the...

[[Click headline to continue reading.]] More...